November 26, 2014 | The venture capital arm of Chinese pharmaceutical company Fosun Pharma, the Hermed Fund, is seeking out a strategic investment partner in Israel and are considering investments in Israeli companies. The pharmaceutical daughter company of Chinese giant Fosun, worth approx. $8 billion, acquired Israeli startup Alma Lasers for $240 million and made investments in Check-Cap and Tyto Care. In addition, the Hermed Fund is considering partnering with a local fund or investment entity that will act as its representative within Israel. Fosun focuses the majority of its efforts on developing generic drugs, biosimilars, diagnosis mechanisms and health services.